158 related articles for article (PubMed ID: 33841814)
1. Functional beverages improve insulin resistance and hepatic steatosis modulating lysophospholipids in diet-induced obese rats.
Rubio-Rodríguez JC; Reynoso-Camacho R; Rocha-Guzmán N; Salgado LM
Food Sci Nutr; 2021 Apr; 9(4):1961-1971. PubMed ID: 33841814
[TBL] [Abstract][Full Text] [Related]
2. Strawberry, Blueberry, and Strawberry-Blueberry Blend Beverages Prevent Hepatic Steatosis in Obese Rats by Modulating Key Genes Involved in Lipid Metabolism.
Sotelo-González AM; Reynoso-Camacho R; Hernández-Calvillo AK; Castañón-Servín AP; García-Gutiérrez DG; Gómez-Velázquez HDJ; Martínez-Maldonado MÁ; de Los Ríos EA; Pérez-Ramírez IF
Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901426
[TBL] [Abstract][Full Text] [Related]
3. 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat-high-fructose diet.
Fouret G; Gaillet S; Lecomte J; Bonafos B; Djohan F; Barea B; Badia E; Coudray C; Feillet-Coudray C
Br J Nutr; 2018 Feb; 119(4):368-380. PubMed ID: 29498345
[TBL] [Abstract][Full Text] [Related]
4. High fat diet incorporated with meat proteins changes biomarkers of lipid metabolism, antioxidant activities, and the serum metabolomic profile in Glrx1
Ahmad MI; Umair Ijaz M; Hussain M; Ali Khan I; Mehmood N; Siddiqi SM; Liu C; Zhao D; Xu X; Zhou G; Li C
Food Funct; 2020 Jan; 11(1):236-252. PubMed ID: 31956867
[TBL] [Abstract][Full Text] [Related]
5. Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism.
Chalhoub G; Jamnik A; Pajed L; Kolleritsch S; Hois V; Bagaric A; Prem D; Tilp A; Kolb D; Wolinski H; Taschler U; Züllig T; Rechberger GN; Fuchs C; Trauner M; Schoiswohl G; Haemmerle G
Mol Metab; 2023 Jun; 72():101725. PubMed ID: 37059417
[TBL] [Abstract][Full Text] [Related]
6. Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice.
Moreira GV; Araujo LCC; Murata GM; Matos SL; Carvalho CRO
Biomed Pharmacother; 2022 Nov; 155():113660. PubMed ID: 36095960
[TBL] [Abstract][Full Text] [Related]
7. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
8. Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet.
Prasomthong J; Limpeanchob N; Daodee S; Chonpathompikunlert P; Tunsophon S
Sci Rep; 2022 Apr; 12(1):7022. PubMed ID: 35487948
[TBL] [Abstract][Full Text] [Related]
9. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
[TBL] [Abstract][Full Text] [Related]
10. Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway.
Yan BF; Pan LF; Quan YF; Sha Q; Zhang JZ; Zhang YF; Zhou LB; Qian XL; Gu XM; Li FT; Wang T; Liu J; Zheng X
World J Gastroenterol; 2023 Aug; 29(31):4744-4762. PubMed ID: 37664157
[TBL] [Abstract][Full Text] [Related]
11. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats.
Xia HM; Wang J; Xie XJ; Xu LJ; Tang SQ
Int J Mol Med; 2019 Oct; 44(4):1523-1530. PubMed ID: 31364723
[TBL] [Abstract][Full Text] [Related]
13. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
15. Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
Papadopoulos G; Legaki AI; Georgila K; Vorkas P; Giannousi E; Stamatakis G; Moustakas II; Petrocheilou M; Pyrina I; Gercken B; Kassi E; Chavakis T; Pateras IS; Panayotou G; Gika H; Samiotaki M; Eliopoulos AG; Chatzigeorgiou A
Metabolism; 2023 Jul; 144():155552. PubMed ID: 36996933
[TBL] [Abstract][Full Text] [Related]
16. Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats.
Yang SY; Zhao NJ; Li XJ; Zhang HJ; Chen KJ; Li CD
Chin J Integr Med; 2012 Apr; 18(4):262-8. PubMed ID: 22457136
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
18. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
[TBL] [Abstract][Full Text] [Related]
19.
Chaidee A; Onsurathum S; Intuyod K; Haonon O; Pannangpetch P; Pongchaiyakul C; Pinlaor P; Pairojkul C; Welbat JU; Ittiprasert W; Cochran CJ; Mann VH; Brindley PJ; Pinlaor S
Am J Trop Med Hyg; 2019 Nov; 101(5):1161-1169. PubMed ID: 31482785
[TBL] [Abstract][Full Text] [Related]
20. High-fructose and high-fat feeding correspondingly lead to the development of lysoPC-associated apoptotic cardiomyopathy and adrenergic signaling-related cardiac hypertrophy.
Huang JP; Cheng ML; Wang CH; Shiao MS; Chen JK; Hung LM
Int J Cardiol; 2016 Jul; 215():65-76. PubMed ID: 27107546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
